retatrutide what is retatrutide clinical trials Results: 28.3% Weight Loss Data Retatrutide Side Effects Research |

By pairing a rapid "research flywheel" with large-scale genomic data, 23andMe Research Institute scientists identified GLP1R and GIPR variants associated with some of the variability in individual response to GLP-1 drugs, helping bridge the gap between patient experiences and precision medicine.

Your Daily Metabolic Ally

Hit your running and weight loss goals while on GLP-1s with the help of mindful strategies.

Using advanced GLP-1 medications with medical oversight, we help patients reduce cravings, improve metabolism, and achieve lasting results through science-based care and ongoing support.

But the more interesting question is not how much weight is lost

Recent Findings GLP-1 receptor agonists have become widely used to treat obesity